Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT139 |
Cell Line |
HT-29 |
Homo sapiens |
IC50 |
= |
55000.0 |
nM |
PMID[8289202] |
NPT4316 |
Individual Protein |
Phospholipase A2 group 1B |
Rattus norvegicus |
IC50 |
= |
100000.0 |
nM |
DOI[10.1016/S0960-894X(01)81260-9] |
NPT183 |
Individual Protein |
Arachidonate 5-lipoxygenase |
Rattus norvegicus |
IC50 |
= |
130000.0 |
nM |
DOI[10.1016/S0960-894X(01)81260-9] |
NPT1557 |
Individual Protein |
Glutathione reductase |
Homo sapiens |
IC50 |
> |
1000000.0 |
nM |
PMID[11551771] |
NPT3172 |
Individual Protein |
Phospholipase A2 group IIA |
Homo sapiens |
Inhibition |
= |
48.9 |
% |
PMID[7629818] |
NPT2852 |
Individual Protein |
Prion protein |
Homo sapiens |
EC50 |
= |
300.0 |
nM |
PMID[12904059] |
NPT4592 |
Cell Line |
CHO-AA8 |
Cricetulus griseus |
IC50 |
= |
1700.0 |
nM |
PMID[2319563] |
NPT2945 |
Individual Protein |
Phospholipase A2 group 1B |
Sus scrofa |
IC50 |
= |
100000.0 |
nM |
DOI[10.1016/S0960-894X(01)81022-2] |
NPT183 |
Individual Protein |
Arachidonate 5-lipoxygenase |
Rattus norvegicus |
IC50 |
= |
130000.0 |
nM |
DOI[10.1016/S0960-894X(01)81022-2] |
NPT545 |
Individual Protein |
Phospholipase A2 group 1B |
Homo sapiens |
Inhibition |
= |
14.9 |
% |
PMID[2066998] |
NPT4062 |
Individual Protein |
Phospholipase A2 group IIA |
Rattus norvegicus |
IC50 |
= |
320000000.0 |
nM |
PMID[8978846] |
NPT3172 |
Individual Protein |
Phospholipase A2 group IIA |
Homo sapiens |
IC50 |
= |
76000000.0 |
nM |
PMID[8978846] |
NPT144 |
Individual Protein |
Telomerase reverse transcriptase |
Homo sapiens |
Inhibition |
= |
82.0 |
% |
PMID[15177454] |
NPT144 |
Individual Protein |
Telomerase reverse transcriptase |
Homo sapiens |
Inhibition |
= |
50.0 |
% |
PMID[15177454] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
EC50 |
= |
500.0 |
nM |
PMID[16860557] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
LD50 |
= |
9.6 |
uM |
PMID[16860557] |
NPT71 |
Cell Line |
HEK293 |
Homo sapiens |
LD50 |
= |
7.6 |
uM |
PMID[16860557] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
LD50 |
= |
7.9 |
uM |
PMID[16860557] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
EC50 |
= |
300.0 |
nM |
PMID[17064077] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
Activity |
= |
500.0 |
nM |
PMID[17064077] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
Activity |
= |
57.0 |
% |
PMID[17064070] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
Activity |
= |
25000000.0 |
RLU/mg |
PMID[17064070] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
EC50 |
= |
800.0 |
nM |
PMID[17201410] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
LD50 |
= |
7.8 |
uM |
PMID[17201410] |
NPT2249 |
Individual Protein |
Histidine-rich protein |
Plasmodium falciparum |
IC50 |
= |
292000.0 |
nM |
PMID[17088494] |
NPT153 |
Individual Protein |
Androgen Receptor |
Homo sapiens |
Inhibition |
= |
72.0 |
% |
PMID[17911242] |
NPT1136 |
Cell Line |
mast cells |
Mus musculus |
Inhibition |
= |
18.4 |
% |
PMID[11520233] |
NPT1136 |
Cell Line |
mast cells |
Mus musculus |
Inhibition |
= |
8.7 |
% |
PMID[11520233] |
NPT2586 |
Individual Protein |
Phospholipase A2, acidic |
Naja naja |
IC50 |
= |
2160000.0 |
nM |
PMID[8984162] |
NPT2586 |
Individual Protein |
Phospholipase A2, acidic |
Naja naja |
Inhibition |
= |
85.5 |
% |
PMID[8984162] |
NPT2586 |
Individual Protein |
Phospholipase A2, acidic |
Naja naja |
IC50 |
= |
2150000.0 |
nM |
PMID[9392883] |
NPT3035 |
Cell Line |
ScN2a |
Mus musculus |
Activity |
= |
2.5 |
uM |
PMID[18556207] |
NPT1229 |
Cell Line |
Huh-7 |
Homo sapiens |
CC50 |
= |
19610.0 |
nM |
PMID[18579783] |
NPT984 |
Cell Line |
Hepatocyte |
|
TC50 |
> |
1.16 |
10'4nM |
PMID[18212104] |
NPT2742 |
Individual Protein |
Aldehyde oxidase |
Homo sapiens |
IC50 |
= |
3300.0 |
nM |
PMID[20853847] |
NPT2933 |
Individual Protein |
Aldehyde oxidase |
Oryctolagus cuniculus |
IC50 |
= |
10000.0 |
nM |
PMID[20853847] |
NPT4069 |
Individual Protein |
Riboflavin-binding protein |
Gallus gallus |
Ki |
= |
6700.0 |
nM |
PMID[21686082] |
NPT4069 |
Individual Protein |
Riboflavin-binding protein |
Gallus gallus |
Kd |
= |
264.0 |
nM |
PMID[21686082] |
NPT616 |
Cell Line |
MDCK |
Canis lupus familiaris |
Ratio |
= |
1.2 |
n.a. |
PMID[21531054] |
NPT616 |
Cell Line |
MDCK |
Canis lupus familiaris |
Ratio |
= |
5.1 |
n.a. |
PMID[21531054] |
NPT2689 |
Individual Protein |
Indoleamine 2,3-dioxygenase 2 |
Mus musculus |
Inhibition |
>= |
55.0 |
% |
PMID[23122865] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
CC50 |
= |
9780.0 |
nM |
PMID[24354316] |
NPT804 |
Cell Line |
HT-22 |
Mus musculus |
EC50 |
= |
9090.0 |
nM |
PMID[24602904] |
NPT2719 |
Individual Protein |
Voltage-gated L-type calcium channel alpha-1C subunit |
Rattus norvegicus |
IC50 |
= |
5200.0 |
nM |
PMID[22761000] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
EC50 |
= |
10440.0 |
nM |
PMID[27992217] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
EC90 |
= |
18.23 |
uM |
PMID[27992217] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
EC50 |
= |
10440.0 |
nM |
PMID[28740614] |
NPT784 |
Cell Line |
MDA-MB-468 |
Homo sapiens |
IC50 |
= |
3960.0 |
nM |
PMID[29232580] |
NPT82 |
Cell Line |
MDA-MB-231 |
Homo sapiens |
IC50 |
= |
3250.0 |
nM |
PMID[29232580] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
4190.0 |
nM |
PMID[29232580] |
NPT784 |
Cell Line |
MDA-MB-468 |
Homo sapiens |
IC50 |
= |
3960.0 |
nM |
PMID[28586716] |
NPT82 |
Cell Line |
MDA-MB-231 |
Homo sapiens |
IC50 |
= |
3250.0 |
nM |
PMID[28586716] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
4190.0 |
nM |
PMID[28586716] |
NPT189 |
Cell Line |
Vero |
Chlorocebus aethiops |
CC50 |
= |
14710.0 |
nM |
DOI[10.1101/2020.03.20.999730] |
NPT1045 |
Cell Line |
U2OS |
Homo sapiens |
LD50 |
= |
2.5 |
uM |
PMID[29211480] |
NPT1045 |
Cell Line |
U2OS |
Homo sapiens |
EC |
= |
0.2 |
uM |
PMID[29211480] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
7500.0 |
nM |
PMID[30684866] |
NPT2846 |
Cell Line |
BHK-21 |
Cricetulus griseus |
CC50 |
= |
18590.0 |
nM |
PMID[31549836] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
EC50 |
= |
7653700.0 |
nM |
PMID[30655955] |
NPT380 |
Cell Line |
U-251 |
Homo sapiens |
IC50 |
= |
5000.0 |
nM |
PMID[30583248] |
NPT4473 |
Cell Line |
WIL2-NS |
Homo sapiens |
CC50 |
= |
4800.0 |
nM |
PMID[33479683] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
CC50 |
= |
7600.0 |
nM |
PMID[33479683] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
31200.0 |
nM |
PMID[12361395] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
28800.0 |
nM |
PMID[12361395] |
NPT1774 |
Protein Family |
Sodium channel alpha subunits; brain (Types I, II, III) |
Homo sapiens |
IC50 |
= |
3300.0 |
nM |
PMID[2579237] |
NPT1774 |
Protein Family |
Sodium channel alpha subunits; brain (Types I, II, III) |
Homo sapiens |
Inhibition |
= |
73.3 |
% |
PMID[2579237] |
NPT991 |
Individual Protein |
Trypanothione reductase |
Trypanosoma cruzi |
Ki |
= |
19000.0 |
nM |
PMID[10639286] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED30 |
= |
5.8 |
uM kg-1 |
DOI[10.1016/S0960-894X(01)81260-9] |
NPT4866 |
Protein Family |
Prostaglandin G/H synthase (cyclooxygenase) |
Ovis aries |
IC50 |
= |
130000.0 |
nM |
DOI[10.1016/S0960-894X(01)81260-9] |
NPT991 |
Individual Protein |
Trypanothione reductase |
Trypanosoma cruzi |
IC50 |
= |
133000.0 |
nM |
PMID[11551771] |
NPT2 |
Others |
Unspecified |
|
Ratio |
= |
11.5 |
n.a. |
PMID[2319563] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
ED50 |
> |
100.0 |
ug ear-1 |
DOI[10.1016/S0960-894X(01)81022-2] |
NPT4747 |
Protein Family |
Cyclooxygenase |
Bos taurus |
IC50 |
= |
32600.0 |
nM |
DOI[10.1016/S0960-894X(01)81022-2] |
NPT474 |
Organism |
Plasmodium berghei |
Plasmodium berghei |
Inhibition |
= |
92.0 |
% |
PMID[7035667] |
NPT474 |
Organism |
Plasmodium berghei |
Plasmodium berghei |
Inhibition |
= |
80.0 |
% |
PMID[7035667] |
NPT2 |
Others |
Unspecified |
|
Inhibition |
= |
93.0 |
% |
PMID[15177454] |
NPT2 |
Others |
Unspecified |
|
Inhibition |
= |
80.0 |
% |
PMID[15177454] |
NPT2 |
Others |
Unspecified |
|
Inhibition |
= |
75.0 |
% |
PMID[15177454] |
NPT485 |
Organism |
Plasmodium falciparum (isolate K1 / Thailand) |
Plasmodium falciparum K1 |
EC50 |
= |
5.0 |
nM |
PMID[15686903] |
NPT485 |
Organism |
Plasmodium falciparum (isolate K1 / Thailand) |
Plasmodium falciparum K1 |
EC50 |
= |
8.0 |
nM |
PMID[15686903] |
NPT485 |
Organism |
Plasmodium falciparum (isolate K1 / Thailand) |
Plasmodium falciparum K1 |
EC50 |
= |
32.0 |
nM |
PMID[15686903] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
73000.0 |
nM |
PMID[15225721] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
= |
11.0 |
nM |
PMID[17371810] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
= |
33.0 |
nM |
PMID[17371810] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
13700.0 |
nM |
PMID[15568764] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
23300.0 |
nM |
PMID[15568764] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
230.0 |
nM |
PMID[18556207] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
0.8 |
uM |
PMID[18556207] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
590.0 |
nM |
PMID[18556207] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
460.0 |
nM |
PMID[18556207] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
2.0 |
uM |
PMID[18556207] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
1880.0 |
nM |
PMID[18556207] |
NPT485 |
Organism |
Plasmodium falciparum (isolate K1 / Thailand) |
Plasmodium falciparum K1 |
IC50 |
= |
43.0 |
nM |
PMID[18395298] |
NPT991 |
Individual Protein |
Trypanothione reductase |
Trypanosoma cruzi |
Ki |
= |
19000.0 |
nM |
PMID[19414258] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
420.0 |
nM |
PMID[19842664] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
300.0 |
nM |
PMID[19842664] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
= |
8.13 |
nM |
PMID[18579783] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
= |
14.22 |
nM |
PMID[18579783] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
41000.0 |
nM |
PMID[20185316] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
936.0 |
nM |
PMID[17417631] |
NPT1188 |
Organism |
Plasmodium yoelii yoelii |
Plasmodium yoelii yoelii |
IC50 |
= |
30000.0 |
nM |
PMID[18212104] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
1100.0 |
nM |
PMID[21277202] |
NPT914 |
Individual Protein |
Acetylcholinesterase |
Bos taurus |
Inhibition |
= |
49.0 |
% |
PMID[21459491] |
NPT67 |
Individual Protein |
Cholinesterase |
Equus caballus |
IC50 |
= |
4500.0 |
nM |
PMID[21459491] |
NPT475 |
Organism |
Plasmodium yoelii |
Plasmodium yoelii |
IC50 |
= |
165.7 |
nM |
PMID[22096101] |
NPT668 |
Individual Protein |
P-glycoprotein 1 |
Homo sapiens |
EC50 |
= |
14400.0 |
nM |
PMID[8862725] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
230.0 |
nM |
PMID[21531054] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
0.8 |
uM |
PMID[21531054] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
590.0 |
nM |
PMID[21531054] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
1880.0 |
nM |
PMID[21531054] |
NPT485 |
Organism |
Plasmodium falciparum (isolate K1 / Thailand) |
Plasmodium falciparum K1 |
IC50 |
= |
43.0 |
nM |
DOI[10.1007/s00044-007-9025-8] |
NPT757 |
Organism |
Plasmodium falciparum 3D7 |
Plasmodium falciparum 3D7 |
IC50 |
= |
13.0 |
nM |
DOI[10.1007/s00044-007-9025-8] |
NPT20576 |
SMALL MOLECULE |
Heme |
n.a. |
IC50 |
= |
41000.0 |
nM |
DOI[10.1007/s00044-007-9025-8] |
NPT27 |
Others |
Unspecified |
|
Activity |
= |
100.0 |
% |
PMID[24900645] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
400.0 |
nM |
PMID[24900645] |
NPT27 |
Others |
Unspecified |
|
CC50 |
= |
3920.0 |
nM |
PMID[24354316] |
NPT5839 |
Protein Complex |
Bacterial DNA-directed RNA polymerase |
Bacteria |
IC50 |
= |
20000.0 |
nM |
PMID[184284] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
2120.0 |
nM |
PMID[27788467] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
11900.0 |
nM |
PMID[27788467] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
4230.0 |
nM |
PMID[27992217] |
NPT2 |
Others |
Unspecified |
|
EC90 |
= |
9.94 |
uM |
PMID[27992217] |
NPT713 |
Individual Protein |
Bile salt export pump |
Homo sapiens |
IC50 |
= |
101100.0 |
nM |
PMID[22961681] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
4230.0 |
nM |
PMID[28740614] |
NPT24746 |
CELL-LINE |
184B5 |
Homo sapiens |
IC50 |
= |
4960.0 |
nM |
PMID[29232580] |
NPT24746 |
CELL-LINE |
184B5 |
Homo sapiens |
IC50 |
= |
4960.0 |
nM |
PMID[28586716] |
NPT2 |
Others |
Unspecified |
|
CC50 |
= |
2.34 |
nM |
PMID[28835807] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
50000.0 |
nM |
DOI[10.1101/2020.03.20.999730] |
NPT22368 |
ORGANISM |
Zika virus |
Zika virus |
EC50 |
= |
2270.0 |
nM |
PMID[31549836] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
2974100.0 |
nM |
PMID[30655955] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
29.0 |
nM |
PMID[30852885] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
18.0 |
nM |
PMID[30852885] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
23.0 |
nM |
PMID[30852885] |
NPT194 |
Organism |
Dengue virus 2 |
Dengue virus 2 |
EC50 |
= |
5300.0 |
nM |
PMID[31128447] |
NPT20556 |
SINGLE PROTEIN |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
-4.1 |
% |
DOI[10.6019/CHEMBL4495564] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
-0.24 |
% |
DOI[10.6019/CHEMBL4495565] |
NPT24749 |
ORGANISM |
Ebolavirus |
Ebolavirus |
IC50 |
= |
1050.0 |
nM |
PMID[32832035] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
7550.0 |
nM |
PMID[32832035] |
NPT20 |
Organism |
Candida albicans |
Candida albicans |
Activity |
= |
50.0 |
% |
PMID[33486051] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
16990.0 |
nM |
PMID[32738977] |
NPT28129 |
CELL-LINE |
UV4 |
Cricetulus griseus |
IC50 |
= |
140.0 |
nM |
PMID[2319563] |